Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 8 | BMC Medicine

Fig. 8

From: Major milestones in translational oncology

Fig. 8

Advances in the treatment of patients with lung cancer over the past 50 years. Advances in the treatment of patients with lung cancer over the past 50 years can be divided into cytotoxic chemotherapy, oncogene-targeted therapy and immunotherapy, with the most recent advances being in oncogene-targeted therapy and immunotherapy. All FDA approvals noted apply to patients with locally advanced or metastatic lung cancer

Back to article page